vimarsana.com

Latest Breaking News On - Joseph fahmy - Page 3 : vimarsana.com

Biotech stocks will outperform in the balance of 2022: Fahmy

Zor Capital's Joseph Fahmy on CNBC's "Worldwide Exchange" explains why he expects biotech stocks to outperform in the back half of 2022.

Joseph fahmyWorldwide exchangeManaging directorZor capital

SPX price prediction: Goldman Sachs Kostin sees a 10% upside

Shopify shares on Thursday edged higher after announcing a strategic partnership with Microsoft and Oracle to offer ERP tools to merchants.

Jim lebenthalGoldman sach david kostinJoseph fahmyCerity partner jim lebenthalZor capital

Joseph Fahmy: Fed will continue to provide equity friendly environment

JPMorgan upgrades Union Pacific to overweight with a PT of $247. Jim Cramer says owning UNP has been a nightmare but Lebenthal agrees with the bullish call.

Joseph fahmyWorldwide exchangeZor capital

vimarsana © 2020. All Rights Reserved.